Skip to main content
Clinical Trials/NCT07207538
NCT07207538Not yet recruitingNot Applicable

Impact of Physical Exercise on Telomere Length and Other Markers of Premature Ageing in First-episode Psychosis.

University of Salamanca0 sites40 target enrollmentStarted: January 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
40
Primary Endpoint
Telomere Length

Study Overview

Brief Summary

Justification: Patients with first-episode psychosis are at increased risk of premature ageing and early mortality, associated with telomere shortening and increased inflammatory markers. Physical exercise has shown protective effects in the general population, but there are no intervention studies in this population.

Objective: To evaluate the effect of a strength training programme on telomere length and other markers of cellular ageing in people with a first episode of psychosis.

Material and methods: Quasi-experimental study with patients aged 18-35 years included in the PRINT programme (Salamanca). Standard treatment will be compared with standard treatment plus a 12-week strength training programme. Telomere length (qPCR), inflammatory and senescence markers (proteomics), body composition, frailty and quality of life will be analysed.

Applicability: The results could support the inclusion of physical exercise programmes as a complementary intervention in early psychosis care, promoting overall health, quality of life and reducing the gap in life expectancy compared to the general population.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Outcomes Assessor)

Masking Description

The persons in charge of the evaluation of the participants will be unaware of the assignment of the participants.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • be at least 18 years of age
  • Having experienced a first psychotic episode in the last 3 years

Exclusion Criteria

  • are unable to read and understand the patient information sheet and sign the informed consent form.

Outcomes

Primary Outcomes

Telomere Length

Time Frame: Baseline and immediately after the intervention

Telomere length will be measured before and after the procedure in kilobases.

Secondary Outcomes

  • Fragility(Baseline and immediately after the intervention)
  • Quality of life(Baseline and immediately after the intervention)
  • Differential plasma profile(Baseline and immediately after the intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Juan Luis Sanchez Gonzalez

Principal investigator. Juan Luis Sánchez González

University of Salamanca

Similar Trials